ArticleScience translational medicine2014

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.

Deborah M Cholon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.